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Background: Antibodies binding to citrullinated proteins are a frequent finding in rheumatoid arthritis patients and
may precede the onset of clinical symptoms several years. The antibodies are a predisposing factor for bone
erosions but their origin is unknown. In this study we analyze in detail the levels of protein bound citrulline and
homocitrulline in several tissue samples of a single erosive arthritic surgery patient.
Methods: Serum antibodies binding to CCP, MCV and citrulline- or homocitrulline-containing type I and II collagen
carboxytelopeptides were measured. Tissue samples of a single RA patient, taken in two separate operations
performed with two-year time span were hydrolyzed and analyzed for citrulline and homocitrulline content by
HPLC.
Results: Protein-bound citrulline and homocitrulline were found in several joint tissues of a RA patient with ACPA-
positive erosive disease. The amount of homocitrulline stayed relatively constant between the different tissues. The
amount of citrulline in erosive tissue was 3-times higher than in non-erosive tissue in the first operation. In the
samples of the second operation 3-4-times higher mean amounts of citrulline were found in two out of the six
tissues investigated.
Conclusions: Homocitrulline is present in rheumatoid nodule together with citrulline. There is more variation in the
amount of citrulline than in the amount of homocitrulline between the tissues. The tissue sample containing the
most citrulline was the most erosive.
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Antibodies binding to citrullinated proteins are a fre-
quent finding in rheumatoid arthritis (RA) patients and
may precede the onset of clinical symptoms several years
[1]. The anti-citrullinated protein antibodies (ACPA) are
a predisposing factor for bone erosions in RA patients
[2]. The ACPA antibody repertoire of RA patients has
been quite specifically characterized [3-5] and possible
candidate antigens for these antibodies have also been
demonstrated in several studies [6-8]. Antibodies binding* Correspondence: sanna.turunen@oulu.fi
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reproduction in any medium, provided the orto carbamylated proteins have been found recently in RA
sera [9] but the presence of homocitrulline-containing
proteins in RA tissues have not been demonstrated yet.
Recent studies on RA have suggested that the original
antigen of ACPA could be in the lungs [10] or in the
gingiva [11]. The inflammation of the joints is still the
most prominent symptom and chronic joint inflammation
resistant to medication is treated surgically. In this study
we analyzed for the first time in detail the levels of protein
bound citrulline and homocitrulline in several tissue sam-
ples of a single erosive arthritic surgery patient.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Turunen et al. Journal of Translational Medicine 2013, 11:224 Page 2 of 5
http://www.translational-medicine.com/content/11/1/224Patient and methods
Patient
47-year-old female RA patient with a disease history of
10 years, at the time of the first operation, described here
due to difficult and resistant local symptoms at right
MTP1 and MTP5 joints. Prior to this several operations
were performed to remove synovitis and rheumatoid
nodules from both hands. The patient used multiple
medication, that included natriumaurothiomalate 50 mg
monthly, methotrexate 12.5 mg once weekly, leflunomide
20 mg daily and prednisolone 2.5 mg daily. Tissue sam-
ples were collected from two separate operations with
two-year time span (Figure 1A and B in the first oper-
ation and 1–6 in the second operation).Histology
Samples were cut from the tissues (A, B and 1–6) frozen
at −70°C, fixed in formalin and embedded in paraffin. 5
μm sections were mounted on glass slides and stained
with hematoxyline-eosine.Assessment of autoantibodies in the patient serum
Serum sample obtained at the time of the second sur-
gery was analyzed for binding anti-CCP (Immunoscan
RA (Mark 2) Euro Diagnostica, Malmö, Sweden) and
anti-MCV (ORG 546, ORGANTEC Diagnostica GmbH,
Mainz, Germany). Also antibodies binding to citrulline
or homocitrulline containing collagen type I and II
carboxytelopeptides were measured from the serum as
described previously [12,13].Figure 1 The patient radiograph taken before the first surgery. The lo
operation and numbered from 1–6 for the second operation.Detection of protein-bound citrulline and homocitrulline
on high-performance liquid chromatography (HPLC)
Six approximately 10 mg (wet weight) samples were cut
from each tissue. The samples were dialyzed 16 h against
0.2 M NH4HCO3, pH 7.4 to separate free amino acids
from protein-bound ones and freeze-dried, then
rehydrated in distilled H2O, freeze-dried and hydrolyzed
in 6 M HCl at 110°C for 16 h and freeze-dried. The sam-
ples were chemically modified and analyzed on HPLC as
reported previously [12]. The values for citrulline and
homocitrulline in the sample were read from the auto-
matically integrated peak area. The sample mass vari-
ation was taken in to account by using a correction
coefficient.Statistical analysis
The peak areas of citrulline and homocitrulline between
tissues were assessed by independent samples Mann–
Whitney U test for the first operation tissues (n=2) and
by Kruskal-Wallis test for the second operation tissues
(n=6) using Statistical Package for Social Science (SPSS)
for Windows version 20 (IBM SPSS Statistics, Armonk,
New York, USA). The differences were considered sig-
nificant at p < 0.05.Ethical considerations
The research plan was approved by the Ethics Commit-
tee of Oulu University Hospital, the guidelines of the
Declaration of Helsinki were followed and an informed
consent was signed by the patient.cations of the samples taken are presented by A and B for the first
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The patient was positive for antibodies binding to CCP
(800.5 U/ml) and MCV (55.9 U/ml) but no antibodies
binding to citrulline- or homocitrulline-containing type I
and II collagen carboxytelopeptides were detected. Tis-
sue samples A and B (Figure 1) were collected during
the first operative treatment to remove rheumatoid
synovitis. Tissue B was from an area where the tissue
was both visually and radiologically eroded. In histo-
logical studies the tissues were classified as rheumatoid
nodules characterized by necrotic tissue surrounded by
palisading macrophages. RA tissue consists of a mixture
of various tissues, such as vascular, epithelial, different
types of fibrotic and necrotic tissues. All samples were
adjacent to synovium, hence some synovial fragments
were present, as shown in Figure 2.
In the HPLC analysis of the first operation tissue sam-
ples the mean level of homocitrulline was lower and
mean level of citrulline 3-times higher in the erosive B
compared to the non-erosive tissue A (Figure 3). In the
Mann–Whitney independent samples U test both the
differences in citrulline and in homocitrulline between
tissues were statistically significant (p <0.001).
The second operation was scheduled after 2-years
follow-up due to synovitis relapse. A more radical oper-
ation was programmed in consensus with the patient
due to extensive synovial tissue growth in multiple sites
and the aim was to remove all active synovitis and hence
6 separate cuts were made. Representative samples were
taken from metatarsal joints (Figure 1: 1, 2, 6) and from
interphalangeal joints (Figure 1: 3, 4, 5). In HPLCFigure 2 Histological images of removed tissues. Numbers correspond
A and 1, B and 2 are samples from same anatomical site, respectively. Arro
macrophages, N indicates necrosis in the rheumatoid nodulus.analysis homocitrulline and citrulline were present in all
samples. The level of homocitrulline stayed more con-
stant between both operations and the different samples
compared to citrulline (Figure 3). In the Kruskal-Wallis
independent sample tests both the differences in citrul-
line and in homocitrulline levels between tissues of the
second operation were statistically significant p = 0.001
and p = 0.003 respectively. In the pairwise comparison
tissue number 5 differed statistically from tissues 1 and
2 with greater amount of homocitrulline (p = 0.003 and
0.022). The amount of citrulline in tissue number 4 was
statistically greater than in tissues 1, 2 and 6 (p = 0.020,
0.024 and 0.029, respectively). Clinically the patient re-
covered from both surgeries without complications and
the patient reported a significant reduction in RA symp-
toms and arthrodesis of the right MTP 1 joint was
cancelled.
Discussion
In this study, we report the detailed analysis of protein-
bound citrulline and homocitrulline in the RA affected
tissues of a severely RA symptomatic patient. Citrulline
and in experimental model also homocitrulline injected
with adjuvant [12] can induce antibodies against
citrullinated proteins that are a predisposing factor for
erosive RA. We hypothesized that our systemically
ACPA positive patient could have citrullinated proteins
locally at the symptomatic site of intended surgery. The
erosions were evident already in the first radiograph and
repeated sampling from surgically removed synovitis tis-
sue revealed citrullinated proteins in the tissues.those shown in Figure 1. Interval between operations was 2 years,
wheads indicate epithelial tissue, * indicates inflammatory cells, mostly
Figure 3 Results of the HPLC-analysis of citrulline and homocitrulline. The auto-integrated HPLC peak areas of A) citrulline and
B) homocitrulline in the six samples analyzed from each of the eight removed foot joint tissues. In the first operation tissue A was non-erosive
and tissue B was from an erosive location.
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of homocitrulline was low compared to citrulline and
stayed more constant between both operations and dif-
ferent tissues (Figure 3A and B). In the postoperative sur-
gical interview the subjective general and especially the feet
symptoms caused by RA were alleviated by the removal of
the diseased tissue. However, it is of interest that the clinical
symptoms were only alleviated after the second, more thor-
ough operation. This suggests that although the primary in-
duction of the ACPA might be elsewhere the removal of
the citrulline and homocitrulline containing tissues affects
the local disease activity. The local presentation of the
citrullinated antigens could be a reason for erosion. Lately
osteoclastogenesis and bone loss induced by antibodies
binding to citrullinated vimentin was demonstrated [14].
Interestingly the PAD expression pattern in osteoclasts is
similar that is found in the macrophages of the inflamed
RA synovium [15,16]. The bone loss in RA is not exclusive
consequence of synovitis, but neither ACPA alone is
enough to cause classical bone erosions [17].
Antibodies binding to carbamylated proteins were re-
cently found in RA patient sera [9]. The presence of
homocitrulline, the product of lysine carbamylation, how-
ever, has not been demonstrated earlier in RA tissues. The
relevance of homocitrulline to RA pathogenesis is not clear,
but at least in animal model protein-bound homocitrulline
injected with adjuvant was able to induce antibodies bind-
ing to citrullinated proteins [12]. Carbamylation can be
caused by inflammation [18] or ageing of tissues [19].
Therefore the differences between our samples could be
explained by two alternative ways explaining either the
low or the high homocitrulline level. High level of
homocitrulline could be a consequence of the chronic in-
flammation related to RA. On the other hand a low level of
homocitrulline could be explained by repair that creates
the RA synovitis tissue as the newly formed tissue has not
gained age-related posttranslational modifications likethe lysine carbamylation to homocitrulline. The highest
homocitrulline value was from MTP 1 joint (A) that was
the most symptomatic and the primary cause for the first
surgical intervention. Bearing this in mind, tissue B was
highly interesting because it had the lowest level of
homocitrulline and high level of citrulline and the tissue
was highly erosive. This would suggest presence of an ac-
tive disease process with increased citrullination in the
newly formed tissue. Recently, neutrophil extracellular
traps were suggested as the source of citrullinated antigens
in RA [20]. We could not detect any neutrophils in the
basic histological analysis of the nodules, only macrophages
and a few plasma cells, though the presence of citrulline in
the chemical analysis was evident.
As limitations for this case report, it should be noted
that the results gained do not necessarily reflect the situ-
ation in other tissue specimens, such as larger joints or
in other RA patients. Also it is notable, that the amount
of citrulline and homocitrulline in each sample was af-
fected by the exact location, where the 10 mg sample
was taken because all specimens were analyzed separ-
ately. Rheumatoid nodules are not uniform, they
consisted of various amounts of necrosis that was
surrounded by different amount of mainly macrophages
and other inflammatory cells, such as lymphocytes so
even the same tissue contained areas that had different
levels of each amino acid. For this same reason the ap-
pearance of the tissue (inflammation and necrosis) could
not be correlated with the HPLC analysis results.Conclusions
This is the first study analyzing in detail the significant
local differences in citrulline and homocitrulline content
of several tissues of a single ACPA-positive patient with
erosive RA and showing the presence of homocitrulline
in rheumatoid nodule tissues.
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